Telomerase inhibitors

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• Telomerase is highly active in most cancer cells, making it a promising target for anticancer drug development.
• Most normal somatic cells exhibit low or undetectable telomerase activity.
• Current research focuses on inhibiting telomerase to halt cancer cell proliferation.

Purpose of the Study:

• To review and evaluate different strategies for inhibiting telomerase activity.
• To discuss the potential of various agents, including antisense oligonucleotides, ribozymes, and G-quadruplex stabilizers.
• To define the criteria for a specific telomerase inhibitor.

Main Methods:

• Review of existing literature on telomerase inhibitors.
• Analysis of different inhibitory approaches targeting telomerase RNA and G-quadruplex structures.
• Discussion of screening methods and challenges in identifying specific inhibitors.

Main Results:

• Antisense approaches targeting telomerase RNA have been extensively studied.
• Ribozymes targeting telomerase have been less investigated.
• Agents stabilizing G-quadruplex structures show potential for telomerase inhibition.
• The specificity of many identified inhibitors remains uncertain.

Conclusions:

• Developing specific telomerase inhibitors is essential for effective cancer therapy.
• A specific inhibitor should halt telomerase activity without immediately affecting cell division.
• Long-term effects of specific inhibitors include telomere shortening, chromosomal fusion, and growth arrest.